Atlas Trials

Ixazomib for Desensitization

Clinical trial NCT03213158 · COMPLETED

Trial details

NCT number
NCT03213158
Sponsor
University of Wisconsin, Madison
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Kidney DiseasesEnd Stage Renal Disease
Start date
2017-09-15
Primary completion
2021-04-16
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.